Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Therapeutic Blocking Anaphylatoxin Receptor Antibodies Services In Europe
14 services found
Manufactured by:Absolute Antibody Ltd based inRedcar, UNITED KINGDOM
Absolute Antibody offers a quick and professional hybridoma sequencing service, also known as antibody sequencing. Hybridoma sequencing is the sequencing of the cDNA encoding the variable heavy (VH) and variable light (VL) domains of your hybridoma cell ...
Manufactured by:LenioBio GmbH based inDüsseldorf, GERMANY
We offer an end-to-end protein service for research-grade protein expression. From cloning to expression and purification, we enable our customers to unlock new potential for their research projects, without occupying their own resources. Combining the advantages of our versatile ALiCE® technology with our experience in protein production, our team of specialists will ensure you get the best ...
Manufactured by:Absolute Antibody Ltd based inRedcar, UNITED KINGDOM
Humanization is a critical step in the development pathway of all therapeutic antibodies derived from non-human sources, such as hybridomas. Absolute Antibody’s Prometheus™ antibody humanization service delivers a panel of humanized variants from your clone, guaranteeing to produce a variant with comparable activity to the parent antibody. Our service focuses on enhancing antibody ...
by:Genmab A/S based inCopenhagen V, DENMARK
Using our antibody expertise to transform how cancer is treated; As a leader in the discovery and development of antibody therapeutics, we are inspired by nature, passionate about innovation and driven by data. Our commitment to patients pushes us to use our antibody biology expertise to pursue and produce differentiated, next-generation cancer treatments. Our research and innovation teams ...
by:Genmab A/S based inCopenhagen V, DENMARK
We aim to invent, develop and commercialize differentiated antibody-based products, which can be utilized in a modular fashion to create unique and tailored therapeutics to transform cancer ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
Our infectious disease work, in partnership with the Bill & Melinda Gates Foundation has built strong capabilities where we are developing product candidates that target pathogens that are predominant in the developing world. ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Creative Biolabs has extensive experience to offer the novel human or humanized antibody services for either therapeutic or laboratory applications. We have three routes in developing human antibodies. The first and most straightforward method is to screen our human antibody libraries. The second method is to immunize premade “humanized” mice and then raise hybridoma cell lines [or to ...
Manufactured by:Absolute Antibody Ltd based inRedcar, UNITED KINGDOM
Polyclonal antibodies are widely used reagents across research and diagnostics. They are generated by immunizing animals with an immunogen and harvesting the animals’ blood to obtain immunoreactive serum. While polyclonal antibodies offer a range of advantages such as excellent performance across different methods, they suffer from high batch-to-batch variability and require the continued ...
by:Selvita S.A. based inKrakow, POLAND
Cell and Molecular Biology Department at Selvita performs In vitro comparative studies of biosimilar insulins and insulin analogs as well as battery of various therapeutic antibodies (e.g. TNFα, VEGF and HER2 inhibitors etc.). These studies should be comparative in nature and should be designed to have appropriate sensitivity to detect relevant differences in the response to the similar ...
by:Revvity Gene Delivery (formerly SIRION Biotech) based inHamburg, GERMANY
In the discovery of oncology therapeutics, Antibody-drug conjugates (ADCs) are rapidly gaining momentum, with hundreds of candidates advancing through clinical development. Whether your priority lies in assessing the epitope binding of your construct, evaluating the cytotoxic potency of the payload, or scrutinizing the efficacy of the linker in cleaving, each facet demands meticulous ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
Innovative antibody-based molecular concepts. New treatments for cancer that leverage our own immune system to attack and destroy cancer cells can provide long-term and durable therapeutic responses in patients suffering from life-threatening malignancies. These benefits for patients have been driven by recently developed therapeutic antibodies binding with high specificity to drug targets on ...
Manufactured by:Fluidic Sciences Ltd based inHertfordshire, UNITED KINGDOM
Fluidic Sciences Ltd. offers the Fluidity One-M instrument, integrated with Microfluidic Diffusional Sizing (MDS) technology, specifically engineered for in-solution analysis of antibodies and their targets throughout various stages of development. The device is designed to ensure stability optimization, target specificity, and modulation of immune responses necessary for therapeutic antibodies, ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
Transformative antibodies from our platform. Our discovery platform enables us to develop fully human therapeutic antibodies for the treatment of immune-related diseases. Therapies using monoclonal antibodies have proven to be effective in several inflammatory and immune diseases. A common approach is to use antibodies to target cytokines, receptors, and other signalling molecules. We are ...
Manufactured by:Dyadic International, Inc. based inJupiter, FLORIDA (USA)
We are building an active pipeline of products for human health by applying our proprietary and patented C1 technology to develop vaccines and antibodies for infectious and other diseases. Vaccine Development: The C1 platform is ready for full commercialization opportunities in recombinant protein ...